Cargando…
Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
OBJECTIVES: 1. To compare the safety and efficacy of Hydroxychloroquine with Ribavirin and standard treatment in patients with non-severe COVID-19 infection 2. To compare the safety and efficacy of standard treatment, Lopinavir-ritonavir with Ribavarin, and Hydroxychloroquine with Ribavirin in patie...
Autores principales: | Panda, Prasan Kumar, Bandyopadhyay, Arkapal, Singh, Budha Charan, Moirangthem, Bikram, Chikara, Gaurav, Saha, Sarama, Bahurupi, Yogesh Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573526/ https://www.ncbi.nlm.nih.gov/pubmed/33081849 http://dx.doi.org/10.1186/s13063-020-04774-5 |
Ejemplares similares
-
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
por: Panda, Prasan Kumar, et al.
Publicado: (2021) -
Predictors of Mortality Among Post-COVID-19 Discharged Patients in Northern India: A Case-Control Study
por: Kumar, Arjun, et al.
Publicado: (2023) -
Disseminated Intravascular Coagulation Score and Sepsis-induced Coagulopathy Score in Prediction of COVID-19 Severity: A Retrospective Analysis
por: Kapoor, Mayank, et al.
Publicado: (2021) -
Fear, Anxiety, Stress, and Depression of Novel Coronavirus (COVID-19) Pandemic Among Patients and Their Healthcare Workers – A Descriptive Study
por: Parchani, Ashwin, et al.
Publicado: (2021) -
A prospective study to evaluate antimicrobial prescribing pattern among admitted patients in hilly Himalayan region of northern India
por: Ravi, Gandham, et al.
Publicado: (2021)